RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > DDMAC’s Bad Ad Program One Year Later

DDMAC’s Bad Ad Program One Year Later

Posted 01 August 2011

On 11 May 2010, the US Food and Drug Administration's (FDA) Division of Drug Marketing, Advertising and Communication (DDMAC) announced that it was launching a new program known as the "Truthful Prescription Drug Advertising and Promotion (Bad Ad Program)" to educate healthcare providers (HCPs) about their role in recognizing and reporting violative drug advertising and promotion.

 

© 2022 Regulatory Affairs Professionals Society.